43 results
8-K
EX-2.1
4wyojso
15 Nov 23
Alkermes Completes Separation of Oncology Business
7:05am
DEFA14A
wbu7la
13 Jun 23
Additional proxy soliciting materials
7:08am
DEFC14A
la6x dxek6jej2
25 May 23
Proxy in contested solicitation
4:03pm
PRER14A
c51vv085p7o7xl
19 May 23
Preliminary revised proxy
5:23pm
PREC14A
lhaa5d1
8 May 23
Preliminary proxy with contested solicitation
4:34pm
DEFC14A
zdy v9pmzk
6 Jun 22
Proxy in contested solicitation
5:29pm
PREC14A
vhmi iyi5dr74rhat7m
26 May 22
Preliminary proxy with contested solicitation
5:29pm
8-K
EX-99.1
h6fib
19 Nov 21
Alkermes Announces the Appointment of Cato T. Laurencin, M.D., Ph.D. to its Board of Directors
7:08am